Breathing in a new way to see lungs: MRI with inhaled gas

NCT ID NCT07305532

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new MRI technique that uses an inhaled gas (perfluoropropane) to create detailed images of the lungs. Researchers will enroll 200 healthy adults aged 18 to 85 to improve the hardware and software needed for this imaging. The goal is to make lung scans clearer and safer without using radiation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

perfluoropropane gas

What this could lead to

If successful, this could lead to a safer, radiation-free way to image lung function, helping diagnose lung diseases earlier.

What could go wrong

This is an early development study in healthy volunteers, so it may not translate to patients. The technique is still being refined and may not improve current imaging methods.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS - MALE AND FEMALE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • St Joseph's Healthcare London

    London, Ontario, N6A 4V2, Canada

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Email: •••••@•••••